JG
Jain Global Portfolio holdings
AUM
$6.43B
This Quarter Return
-2.08%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$4.89B
AUM Growth
+$1.55B
(+47%)
Cap. Flow
+$1.57B
Cap. Flow
% of AUM
32.16%
Top 10 Holdings %
Top 10 Hldgs %
38.27%
Holding
1,383
New
643
Increased
198
Reduced
147
Closed
368
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$627M |
| 2 |
NVIDIA
NVDA
|
+$190M |
| 3 |
Microsoft
MSFT
|
+$55.5M |
| 4 |
PPG Industries
PPG
|
+$47.7M |
| 5 |
Tesla
TSLA
|
+$37.8M |
Top Sells
| 1 |
Arthur J. Gallagher & Co
AJG
|
+$81M |
| 2 |
RTX Corp
RTX
|
+$57.5M |
| 3 |
Broadcom
AVGO
|
+$53.6M |
| 4 |
FedEx
FDX
|
+$52.9M |
| 5 |
ConocoPhillips
COP
|
+$51.7M |
Sector Composition
| 1 | Technology | 19.55% |
| 2 | Industrials | 10.5% |
| 3 | Consumer Discretionary | 8.61% |
| 4 | Healthcare | 6.48% |
| 5 | Materials | 5.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
951
Neumora Therapeutics
NMRA
$262M
| $53.4K | ﹤0.01% |
+53,387
| New | +$53.4K |
|
|
ETWO
952
DELISTED
E2open Parent Holdings
ETWO
| $51.3K | ﹤0.01% |
+25,656
| New | +$51.3K |
|
953
Leslie's
LESL
$62M
| $51.2K | ﹤0.01% |
69,595
-80,775
| -54% | -$59.4K |
|
954
Alta Equipment Group
ALTG
$236M
| $49.7K | ﹤0.01% |
+10,595
| New | +$49.7K |
|
955
Editas Medicine
EDIT
$245M
| $48.9K | ﹤0.01% |
42,186
-62,630
| -60% | -$72.7K |
|
956
Olema Pharmaceuticals
OLMA
$553M
| $46.6K | ﹤0.01% |
+12,396
| New | +$46.6K |
|
|
PGRE
957
Paramount Group
PGRE
$1.59B
| $46.5K | ﹤0.01% |
+10,823
| New | +$46.5K |
|
958
Arbutus Biopharma
ABUS
$870M
| $46.1K | ﹤0.01% |
+13,200
| New | +$46.1K |
|
959
Pliant Therapeutics
PLRX
$100M
| $45.9K | ﹤0.01% |
+34,021
| New | +$45.9K |
|
960
Mobile Infrastructure Corporation Common Stock
BEEP
$154M
| $45.7K | ﹤0.01% |
+10,969
| New | +$45.7K |
|
961
Erasca
ERAS
$454M
| $42.8K | ﹤0.01% |
+31,246
| New | +$42.8K |
|
962
Veritone
VERI
$227M
| $42.2K | ﹤0.01% |
+18,164
| New | +$42.2K |
|
963
TTEC Holdings
TTEC
$176M
| $42.1K | ﹤0.01% |
+12,788
| New | +$42.1K |
|
964
Genasys
GNSS
$97.5M
| $42K | ﹤0.01% |
+18,503
| New | +$42K |
|
965
Tango Therapeutics
TNGX
$753M
| $41.5K | ﹤0.01% |
30,303
-19,489
| -39% | -$26.7K |
|
|
IVAC
966
DELISTED
Intevac Inc
IVAC
| $40.6K | ﹤0.01% |
+10,155
| New | +$40.6K |
|
967
Opko Health
OPK
$1.13B
| $40.2K | ﹤0.01% |
+24,200
| New | +$40.2K |
|
968
Immunic
IMUX
$79M
| $39.9K | ﹤0.01% |
+36,622
| New | +$39.9K |
|
969
C4 Therapeutics
CCCC
$190M
| $38.7K | ﹤0.01% |
+24,203
| New | +$38.7K |
|
970
Zevia
ZVIA
$184M
| $38.7K | ﹤0.01% |
+17,915
| New | +$38.7K |
|
971
Fulcrum Therapeutics
FULC
$371M
| $37.6K | ﹤0.01% |
13,051
-2,358
| -15% | -$6.79K |
|
972
Larimar Therapeutics
LRMR
$346M
| $36K | ﹤0.01% |
16,729
-15,058
| -47% | -$32.4K |
|
973
Senseonics Holdings
SENS
$376M
| $33.9K | ﹤0.01% |
+51,689
| New | +$33.9K |
|
974
NovaGold Resources
NG
$2.8B
| $33.8K | ﹤0.01% |
+11,574
| New | +$33.8K |
|
975
Vivid Seats
SEAT
$113M
| $32.4K | ﹤0.01% |
+547
| New | +$32.4K |
|